Rudolf Lucas
Gründer bei APEPTICO Forschung & Entwicklung GmbH
Profil
Rudolf Lucas is the founder of APEPTICO Forschung & Entwicklung GmbH, which was founded in 2008.
He held the title of Chief Scientific Officer at the company starting in 2010.
Dr. Lucas is currently working at Georgia Health Sciences University as a Professor since 2007.
In the past, he has worked at the University of Geneva, Weizmann Institute of Science, and Universität Konstanz, holding the title of Principal at each institution.
Aktive Positionen von Rudolf Lucas
| Unternehmen | Position | Beginn |
|---|---|---|
APEPTICO Forschung & Entwicklung GmbH
 APEPTICO Forschung & Entwicklung GmbH Miscellaneous Commercial ServicesCommercial Services APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria. | Gründer | 20.01.2010 |
| Georgia Health Sciences University | Corporate Officer/Principal | 05.06.2009 |
Ehemalige bekannte Positionen von Rudolf Lucas
| Unternehmen | Position | Ende |
|---|---|---|
| Weizmann Institute of Science | Corporate Officer/Principal | - |
| Universität Konstanz | Corporate Officer/Principal | - |
| University of Geneva | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
APEPTICO Forschung & Entwicklung GmbH
APEPTICO Forschung & Entwicklung GmbH Miscellaneous Commercial ServicesCommercial Services APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria. | Commercial Services |
